Craig is the founder/CEO of compliance operations software company Hyperproof and an expert in the compliance, risk, and technology space. In today’s volatile environment, organizations need to have ...
Stanford researchers have developed a new biosensor with the ability to continuously detect and monitor the blood concentration of insulin and glucose in real time. The system, dubbed the Real-time ...
Aim: To demonstrate the potential of in-line nanoparticle size measurements using the NanoFlowSizer (NFS) as a PAT method. To achieve real-time process control by establishing automated regulation of ...
Audit season shouldn't feel like a crisis. But for most security teams, it does. Compliance officers scramble through Slack threads hunting for patch logs. CISOs pull all-nighters assembling ...
You don’t have to go it alone when searching for and maintaining the perfect batch. Through machine learning and AI-based batch control, the arduous search becomes easier to realize.
Claims data reveal larger hemoglobin A1c decreases in people with type 2 diabetes who use continuous glucose monitoring and semaglutide compared with semaglutide alone. Study Design: Using US health ...
Risk-sharing agreements incentivize high-quality diabetes care by linking reimbursement to value-based outcomes, addressing social determinants of health. Continuous glucose monitoring (CGM) is ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results